Abstract
Objective:
To conduct field testing of the ExACT CM compliance monitoring device and provide results to the manufacturer.
Design:
Questionnaires, interviews, and patient diaries were used to collect data on targeted product attributes of interest.
Setting:
The Veterans Affairs Medical Center outpatient anticoagulation clinic in Tucson, AZ.
Subjects:
A convenience sample of 31 ambulatory male patients (average 68 ± 0.5 y) who had been stabilized on warfarin therapy for at least one month.
Main Outcome Measures:
Scaled attitudinal scores and open-ended comments on device attributes.
Results:
Data were collected for 28 days per patient. The device was determined to be both functional and acceptable to patients.
Conclusions:
Results suggest that it is feasible to market ExACT CM for use by the pharmaceutical industry in clinical research.
Get full access to this article
View all access options for this article.
